XML 71 R47.htm IDEA: XBRL DOCUMENT v3.26.1
Disclosure on Individual Items of the Consolidated Financial Statements - Schedule of Earnings Per Share (Details) - EUR (€)
€ / shares in Units, € in Thousands, shares in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disclosure on Individual Items of the Consolidated Financial Statements - Schedule of Earnings Per Share (Details) [Line Items]      
Profit/loss for the period (attributable to shareholders of the parent) (kEUR) (in Euro) € (55,190) € (97,958) € (55,081)
Weighted average number of ordinary shares outstanding (in k units) (basic) 56,394 51,224 48,919
Weighted average number of ordinary shares outstanding (in k units) diluted 56,394 51,224 48,919
Effects of dilution from: *)      
Weighted average number of ordinary shares outstanding (in k units) (diluted) 61,558 57,724 49,208
Basic loss per share (€) (in Euro per share) € (0.98) € (1.91) € (1.13)
Diluted loss per share (€) (in Euro per share) € (0.98) € (1.91) € (1.13)
RSU [Member]      
Effects of dilution from: *)      
Effects of dilution 207 357 288
NQSO [Member]      
Effects of dilution from: *)      
Effects of dilution 541 464
Warrants [Member]      
Effects of dilution from: *)      
Effects of dilution 4,416 5,680